Molecular Subtyping of Colorectal Cancer: Time to Explore Both Intertumoral and Intratumoral Heterogeneity to Evaluate Patient Outcome
Authors:
- 1 January 2015
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 148 (1) , 10-13
Abstract
No abstract availableFunding Information
- U.S. Public Health Service (DK067287, CA162147, CA082223)
This publication has 20 references indexed in Scilit:
- Recurrent R-spondin fusions in colon cancerNature, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Genome-scale analysis of aberrant DNA methylation in colorectal cancerGenome Research, 2011
- CpG islands and the regulation of transcriptionGenes & Development, 2011
- Molecular Genetics of Colorectal CancerAnnual Review of Pathology: Mechanisms of Disease, 2011
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerJournal of Clinical Oncology, 2010
- Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative StudyJournal of Clinical Oncology, 2007
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Systematic Review of Microsatellite Instability and Colorectal Cancer PrognosisJournal of Clinical Oncology, 2005